The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation

The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation

Background The benefit of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) on major bleeding was less prominent among atrial fibrillation (AF) patients with polypharmacy in post-hoc randomized controlled trials analyses. Whether this phenomenon also exists in routine care is un...

Full description

Bibliographic Details
Main Authors: Carline J. van den Dries, Sander van Doorn, Patrick Souverein, Romin Pajouheshnia, Karel G.M. Moons, Arno W. Hoes, Geert-Jan Geersing, Hendrika A. van den Ham
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2020-10-01
Series:TH Open
Subjects:
atrial fibrillation
anticoagulation
polypharmacy
major bleeding
effect modification
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1721499

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1721499

Similar Items